Our metabolic reprogramming technology revitalizes terminally exhausted T cells, restores their proliferative capacity and killing power, ultimately leads to a cure of cancer. It has shown great therapeutic potential and safety in animal tumor models. swissinfo.ch/eng/business/s…
www.swissinfo.ch Swiss cancer research could ‘boost’ immunotherapy Swiss researchers have made major advances in cancer immunotherapy but bringing these to patients faces challenges.